U.S. markets close in 1 hour 6 minutes
  • S&P 500

    4,145.04
    -18.25 (-0.44%)
     
  • Dow 30

    34,197.41
    -130.38 (-0.38%)
     
  • Nasdaq

    13,359.89
    -19.16 (-0.14%)
     
  • Russell 2000

    2,226.30
    -0.82 (-0.04%)
     
  • Crude Oil

    65.44
    -0.83 (-1.25%)
     
  • Gold

    1,869.60
    +2.00 (+0.11%)
     
  • Silver

    28.45
    +0.19 (+0.69%)
     
  • EUR/USD

    1.2234
    +0.0077 (+0.64%)
     
  • 10-Yr Bond

    1.6450
    +0.0050 (+0.30%)
     
  • GBP/USD

    1.4186
    +0.0049 (+0.35%)
     
  • USD/JPY

    108.8600
    -0.3400 (-0.31%)
     
  • BTC-USD

    42,638.60
    -974.10 (-2.23%)
     
  • CMC Crypto 200

    1,192.41
    -60.73 (-4.85%)
     
  • FTSE 100

    7,034.24
    +1.39 (+0.02%)
     
  • Nikkei 225

    28,406.84
    +582.01 (+2.09%)
     

Simulations Plus Sets Date for First Quarter Fiscal Year 2021 Earnings Release and Conference Call

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

Conference call to be on Monday, January 11, 2021, at 4:15 p.m. ET

Simulations Plus, Inc. (Nasdaq: SLP), announced today that it will report its financial results for the first quarter of fiscal year 2021, ended November 30, 2020, after the close of the financial markets on Monday, January 11, 2021.

The Company will host a conference call on January 11, 2021, at 4:15 p.m. Eastern Time. All interested parties are invited to join the call by registering here or by calling 1-201-389-0879. Please join five to 10 minutes before the scheduled start time. The call will be simulcast live on the Internet, and the webcast will be available on the Investors page of the Simulations Plus website under Conference Calls & Presentations. A replay of the webcast will be available on the website approximately one hour following the call.

About Simulations Plus, Inc.

Simulations Plus, Inc., is a leading provider of modeling and simulation software and consulting services supporting drug discovery, development research, and regulatory submissions. With our subsidiaries, Cognigen, DILIsym Services, and Lixoft, we offer solutions which bridge machine learning, physiologically based pharmacokinetics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. Our technology is licensed and applied by major pharmaceutical, biotechnology, chemical, consumer goods companies and regulatory agencies worldwide. For more information, visit our website at www.simulations-plus.com.

Follow us on Twitter | LinkedIn | YouTube

View source version on businesswire.com: https://www.businesswire.com/news/home/20210104005212/en/

Contacts

Simulations Plus Investor Relations
Ms. Renee Bouche
661-723-7723
renee@simulations-plus.com

Hayden IR
Mr. Cameron Donahue
651-653-1854
slp@haydenir.com